MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-GJ-22-0190223
Omicron Pharma Private Limited
Omicron Pharma Private Limited - pharma in Surat, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.1 Cr
▼ 3% YoY
Net profit · FY 2025
₹1.61 Lakh
Net margin 0.8%
EBITDA · FY 2025
₹8.06 Lakh
EBITDA margin 3.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2.5 Lakh
Issued & subscribed
Open charges
₹36 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
5
As per MCA filings
About Omicron Pharma Private Limited
Data last updated:
Omicron Pharma Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2022.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2022PTC132698. Its GSTIN is 24AADCO8015B1ZY (Gujarat). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2.5 Lakh. It is led by directors including Monikaben Jatinbhai Patel and Hiteshkumar Madhubhai Paneliya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 10 – 11 Block No. 212 Shiv City Industries – 4 Mankana Tal. Kamrej, Surat, Gujarat, India – 394325.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.1 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹1.61 Lakh (net margin 0.8%) and EBITDA of ₹8.06 Lakh (EBITDA margin 3.8%).
As per MCA filings, the company has open charges of ₹36 Lakh on record.
Omicron Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-22-0190223).
Company details
CIN U24110GJ2022PTC132698
Registration Number 132698
Incorporation Date 07 June 2022
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-GJ-22-0190223
Key People
Monikaben Jatinbhai Patel Director Hiteshkumar Madhubhai Paneliya Director Hemrajbhai Babubhai Anghan Director Recognitions & Rankings of Omicron Pharma
Contact details
Omicron Pharma Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 10 – 11 Block No. 212 Shiv City Industries – 4 Mankana Tal. Kamrej, Surat, Gujarat, India – 394325
- IndustryPharma, Drug Formulation & Development, API Manufacturers, Pharma Contract R&D
To see the full contact details of Omicron Pharma Private Limited, buy the company report.
Comprehensive company report
Omicron Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Omicron Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Omicron Pharma Private Limited, buy the company report.
Financials of Omicron Pharma Private Limited
FY 2024 filings availableOmicron Pharma Private Limited reported revenue of ₹2.1 Cr (down 3% YoY) for FY 2025.
Revenue · FY 2025
₹2.1 Cr ▼ 3%
Net profit · FY 2025
₹1.61 Lakh margin 0.8%
EBITDA · FY 2025
₹8.06 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
EBITDA CAGR growth
1 year
▲ 10%
Revenue fell 3% in the latest year. EBITDA rose 10% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹8.06 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.61 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.8% | ||
| Net Profit Margin | 0.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Omicron Pharma Private Limited, buy the company report.
Board of directors of Omicron Pharma Private Limited
Omicron Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Monikaben Jatinbhai Patel Also directs: Edges Medicare Private Limited | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
| Hiteshkumar Madhubhai Paneliya Also directs: Edges Medicare Private Limited, Evaan Softtech Private Limited | Director | 07 Jun 2022 | 4 Years 4 Months | Current |
| Hemrajbhai Babubhai Anghan Also directs: Edges Medicare Private Limited | Director | 07 Jun 2022 | 4 Years 4 Months | Current |
| Abhaykumar Ashokbhai Tandel Also directs: Edges Medicare Private Limited | Director | 07 Jun 2022 | 4 Years 4 Months | Current |
| Dharmesh Rameshbhai Kathiriya Also directs: Edges Medicare Private Limited | Director | 07 Jun 2022 | 4 Years 4 Months | Current |
Auditor
Omicron Pharma Private Limited is audited by RAVI VAGHASIYA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI VAGHASIYA & ASSOCIATES | FY 2023 | 166450 |
Shareholding
The shareholding of Omicron Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Omicron Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹36 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2022 | 100657940 | Axis Bank Limited | ₹36 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Omicron Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omicron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Omicron Pharma Private Limited has 1 active EPFO establishment as of Apr 04, 2024.
Active EPFO establishments
1
GST
Omicron Pharma has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCO8015B1ZY | Gujarat | Active | 15 Jul 2022 |
| 29AADCO8015B1ZO | Karnataka | Active | 04 Aug 2022 |
| 19AADCO8015B1ZP | West Bengal | Active | 03 Nov 2022 |
| 06AADCO8015B1ZW | Haryana | Active | 16 Dec 2022 |
To see the full GST registrations and return filing status of Omicron Pharma Private Limited, buy the company report.
Recent activity
Omicron Pharma Private Limited has 6 board changes on record since 2022: 5 appointments and 1 cessation. The latest: Monikaben Jatinbhai Patel ceased to be Additional Director on 29 Sep 2024.
AGM
Omicron Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Monikaben Jatinbhai Patel ceased to be Additional Director.
Filing
Omicron Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Appointed
Monikaben Jatinbhai Patel was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 36.00 Lakh with Charge ID 100657940 was registered on 15 Dec 2022.
Appointed
Abhaykumar Ashokbhai Tandel was appointed as Director.
Appointed
Dharmesh Rameshbhai Kathiriya was appointed as Director.
Appointed
Hemrajbhai Babubhai Anghan was appointed as Director.
Appointed
Hiteshkumar Madhubhai Paneliya was appointed as Director.
Incorporation
07 Jun 2022
Omicron Pharma Private Limited was registered on 07 Jun 2022 with Roc Ahmedabad & aged 4 years 4 months as per MCA records.
Frequently asked questions
Omicron Pharma is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2022 (4+ years old) and is registered under CIN U24110GJ2022PTC132698.
Omicron Pharma has 5 current directors:
- Monikaben Jatinbhai Patel - Director
- Hiteshkumar Madhubhai Paneliya - Director
- Hemrajbhai Babubhai Anghan - Director
- Abhaykumar Ashokbhai Tandel - Director
- Dharmesh Rameshbhai Kathiriya - Director
The latest financial statements of Omicron Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Omicron Pharma is 24AADCO8015B1ZY, registered in Gujarat. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 29AADCO8015B1ZO (Karnataka), 19AADCO8015B1ZP (West Bengal), 06AADCO8015B1ZW (Haryana).
The CIN (Corporate Identification Number) of Omicron Pharma is U24110GJ2022PTC132698. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omicron Pharma was incorporated on 07 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Monikaben Jatinbhai Patel ceased to be Additional Director on 29 Sep 2024. Monikaben Jatinbhai Patel was appointed as Director on 18 Mar 2024. Abhaykumar Ashokbhai Tandel was appointed as Director on 07 Jun 2022. Omicron Pharma has 6 board changes on record in total.
Yes, Omicron Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-22-0190223).
The registered office of Omicron Pharma is at Plot No. 10 – 11 Block No. 212 Shiv City Industries – 4 Mankana Tal. Kamrej, Surat, Gujarat, India – 394325.
Omicron Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages